SutroVax Finds $22M
South San Francisco-based SutroVax, a biopharmaceuticals startup that is developing vaccines for infection disease targets, said this morning that it has raised $22M in a Series A funding. The funding was led by Abingworth, and also included Longitude Capital, Roche Venture Fund and CTI Life Sciences Fund. The company--which is a spinout of Sutro Biopharma--said it has a license from Sutro Biopharma for its technology.
posted on Thursday, July 23, 2015 (Link to more information)
Related companies:
SutroVax
Related stories:
> SutroVax Finds $64M For Pneumococcal Vaccines
> Prismatic Finds $15M For Personalized News
> PocketMath Finds $10M
> Eventbrite Finds $6.46M
> Drawbridge Finds $6.5M
silicontap.com Home